1 Market Overview

1.1 Product Overview and Scope of Phage Therapy

1.2 Classification of Phage Therapy by Type

1.2.1 Overview: Global Phage Therapy Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Phage Therapy Revenue Market Share by Type in 2021

1.2.3 DsDNA Bacteriophage

1.2.4 SsDNA Bacteriophage

1.2.5 SsRNA Bacteriophage

1.2.6 Others

1.3 Global Phage Therapy Market by Application

1.3.1 Overview: Global Phage Therapy Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Animal Health

1.3.3 Aquaculture

1.3.4 Agriculture

1.3.5 Food Industry

1.3.6 Human Health

1.3.7 Others

1.4 Global Phage Therapy Market Size & Forecast

1.5 Global Phage Therapy Market Size and Forecast by Region

1.5.1 Global Phage Therapy Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Phage Therapy Market Size by Region, (2017-2022)

1.5.3 North America Phage Therapy Market Size and Prospect (2017-2028)

1.5.4 Europe Phage Therapy Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Phage Therapy Market Size and Prospect (2017-2028)

1.5.6 South America Phage Therapy Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Phage Therapy Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Phage Therapy Market Drivers

1.6.2 Phage Therapy Market Restraints

1.6.3 Phage Therapy Trends Analysis

2 Company Profiles

2.1 NPO Microgen

2.1.1 NPO Microgen Details

2.1.2 NPO Microgen Major Business

2.1.3 NPO Microgen Phage Therapy Product and Solutions

2.1.4 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 NPO Microgen Recent Developments and Future Plans

2.2 Proteon Pharmaceuticals

2.2.1 Proteon Pharmaceuticals Details

2.2.2 Proteon Pharmaceuticals Major Business

2.2.3 Proteon Pharmaceuticals Phage Therapy Product and Solutions

2.2.4 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Proteon Pharmaceuticals Recent Developments and Future Plans

2.3 Phagelux

2.3.1 Phagelux Details

2.3.2 Phagelux Major Business

2.3.3 Phagelux Phage Therapy Product and Solutions

2.3.4 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Phagelux Recent Developments and Future Plans

2.4 Intralytix

2.4.1 Intralytix Details

2.4.2 Intralytix Major Business

2.4.3 Intralytix Phage Therapy Product and Solutions

2.4.4 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Intralytix Recent Developments and Future Plans

2.5 Micreos

2.5.1 Micreos Details

2.5.2 Micreos Major Business

2.5.3 Micreos Phage Therapy Product and Solutions

2.5.4 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Micreos Recent Developments and Future Plans

2.6 Eliava BioPreparations

2.6.1 Eliava BioPreparations Details

2.6.2 Eliava BioPreparations Major Business

2.6.3 Eliava BioPreparations Phage Therapy Product and Solutions

2.6.4 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Eliava BioPreparations Recent Developments and Future Plans

2.7 Locus Biosciences,Inc

2.7.1 Locus Biosciences,Inc Details

2.7.2 Locus Biosciences,Inc Major Business

2.7.3 Locus Biosciences,Inc Phage Therapy Product and Solutions

2.7.4 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Locus Biosciences,Inc Recent Developments and Future Plans

2.8 Pharmex Group,LLC

2.8.1 Pharmex Group,LLC Details

2.8.2 Pharmex Group,LLC Major Business

2.8.3 Pharmex Group,LLC Phage Therapy Product and Solutions

2.8.4 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Pharmex Group,LLC Recent Developments and Future Plans

2.9 Pherecydes Pharma

2.9.1 Pherecydes Pharma Details

2.9.2 Pherecydes Pharma Major Business

2.9.3 Pherecydes Pharma Phage Therapy Product and Solutions

2.9.4 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Pherecydes Pharma Recent Developments and Future Plans

2.10 APS Biocontrol Ltd. (APS)

2.10.1 APS Biocontrol Ltd. (APS) Details

2.10.2 APS Biocontrol Ltd. (APS) Major Business

2.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Product and Solutions

2.10.4 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 APS Biocontrol Ltd. (APS) Recent Developments and Future Plans

2.11 Qingdao Phagepharm Bio-tech

2.11.1 Qingdao Phagepharm Bio-tech Details

2.11.2 Qingdao Phagepharm Bio-tech Major Business

2.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Product and Solutions

2.11.4 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Qingdao Phagepharm Bio-tech Recent Developments and Future Plans

2.12 Fixed-Phage Limited

2.12.1 Fixed-Phage Limited Details

2.12.2 Fixed-Phage Limited Major Business

2.12.3 Fixed-Phage Limited Phage Therapy Product and Solutions

2.12.4 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Fixed-Phage Limited Recent Developments and Future Plans

2.13 Zeptometrix

2.13.1 Zeptometrix Details

2.13.2 Zeptometrix Major Business

2.13.3 Zeptometrix Phage Therapy Product and Solutions

2.13.4 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Zeptometrix Recent Developments and Future Plans

2.14 Phage International, Inc.

2.14.1 Phage International, Inc. Details

2.14.2 Phage International, Inc. Major Business

2.14.3 Phage International, Inc. Phage Therapy Product and Solutions

2.14.4 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Phage International, Inc. Recent Developments and Future Plans

2.15 MicroMir

2.15.1 MicroMir Details

2.15.2 MicroMir Major Business

2.15.3 MicroMir Phage Therapy Product and Solutions

2.15.4 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 MicroMir Recent Developments and Future Plans

2.16 iNtODEWORLD, Inc.

2.16.1 iNtODEWORLD, Inc. Details

2.16.2 iNtODEWORLD, Inc. Major Business

2.16.3 iNtODEWORLD, Inc. Phage Therapy Product and Solutions

2.16.4 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 iNtODEWORLD, Inc. Recent Developments and Future Plans

2.17 NEXTBIOTICS

2.17.1 NEXTBIOTICS Details

2.17.2 NEXTBIOTICS Major Business

2.17.3 NEXTBIOTICS Phage Therapy Product and Solutions

2.17.4 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 NEXTBIOTICS Recent Developments and Future Plans

2.18 Armata Pharmaceuticals, Inc.

2.18.1 Armata Pharmaceuticals, Inc. Details

2.18.2 Armata Pharmaceuticals, Inc. Major Business

2.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Product and Solutions

2.18.4 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Armata Pharmaceuticals, Inc. Recent Developments and Future Plans

2.19 Innophage

2.19.1 Innophage Details

2.19.2 Innophage Major Business

2.19.3 Innophage Phage Therapy Product and Solutions

2.19.4 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Innophage Recent Developments and Future Plans

2.20 Adaptive Phage Therapeutics

2.20.1 Adaptive Phage Therapeutics Details

2.20.2 Adaptive Phage Therapeutics Major Business

2.20.3 Adaptive Phage Therapeutics Phage Therapy Product and Solutions

2.20.4 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Adaptive Phage Therapeutics Recent Developments and Future Plans

2.21 TechnoPhage

2.21.1 TechnoPhage Details

2.21.2 TechnoPhage Major Business

2.21.3 TechnoPhage Phage Therapy Product and Solutions

2.21.4 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 TechnoPhage Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Phage Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Phage Therapy Players Market Share in 2021

3.2.2 Top 10 Phage Therapy Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Phage Therapy Players Head Office, Products and Services Provided

3.4 Phage Therapy Mergers & Acquisitions

3.5 Phage Therapy New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Phage Therapy Revenue and Market Share by Type (2017-2022)

4.2 Global Phage Therapy Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Phage Therapy Revenue Market Share by Application (2017-2022)

5.2 Global Phage Therapy Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Phage Therapy Revenue by Type (2017-2028)

6.2 North America Phage Therapy Revenue by Application (2017-2028)

6.3 North America Phage Therapy Market Size by Country

6.3.1 North America Phage Therapy Revenue by Country (2017-2028)

6.3.2 United States Phage Therapy Market Size and Forecast (2017-2028)

6.3.3 Canada Phage Therapy Market Size and Forecast (2017-2028)

6.3.4 Mexico Phage Therapy Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Phage Therapy Revenue by Type (2017-2028)

7.2 Europe Phage Therapy Revenue by Application (2017-2028)

7.3 Europe Phage Therapy Market Size by Country

7.3.1 Europe Phage Therapy Revenue by Country (2017-2028)

7.3.2 Germany Phage Therapy Market Size and Forecast (2017-2028)

7.3.3 France Phage Therapy Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Phage Therapy Market Size and Forecast (2017-2028)

7.3.5 Russia Phage Therapy Market Size and Forecast (2017-2028)

7.3.6 Italy Phage Therapy Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Phage Therapy Revenue by Type (2017-2028)

8.2 Asia-Pacific Phage Therapy Revenue by Application (2017-2028)

8.3 Asia-Pacific Phage Therapy Market Size by Region

8.3.1 Asia-Pacific Phage Therapy Revenue by Region (2017-2028)

8.3.2 China Phage Therapy Market Size and Forecast (2017-2028)

8.3.3 Japan Phage Therapy Market Size and Forecast (2017-2028)

8.3.4 South Korea Phage Therapy Market Size and Forecast (2017-2028)

8.3.5 India Phage Therapy Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Phage Therapy Market Size and Forecast (2017-2028)

8.3.7 Australia Phage Therapy Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Phage Therapy Revenue by Type (2017-2028)

9.2 South America Phage Therapy Revenue by Application (2017-2028)

9.3 South America Phage Therapy Market Size by Country

9.3.1 South America Phage Therapy Revenue by Country (2017-2028)

9.3.2 Brazil Phage Therapy Market Size and Forecast (2017-2028)

9.3.3 Argentina Phage Therapy Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Phage Therapy Revenue by Type (2017-2028)

10.2 Middle East & Africa Phage Therapy Revenue by Application (2017-2028)

10.3 Middle East & Africa Phage Therapy Market Size by Country

10.3.1 Middle East & Africa Phage Therapy Revenue by Country (2017-2028)

10.3.2 Turkey Phage Therapy Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Phage Therapy Market Size and Forecast (2017-2028)

10.3.4 UAE Phage Therapy Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Phage Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Phage Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Phage Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Phage Therapy Revenue (USD Million) by Region (2017-2022)

Table 5. Global Phage Therapy Revenue Market Share by Region (2023-2028)

Table 6. NPO Microgen Corporate Information, Head Office, and Major Competitors

Table 7. NPO Microgen Major Business

Table 8. NPO Microgen Phage Therapy Product and Solutions

Table 9. NPO Microgen Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Proteon Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 11. Proteon Pharmaceuticals Major Business

Table 12. Proteon Pharmaceuticals Phage Therapy Product and Solutions

Table 13. Proteon Pharmaceuticals Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Phagelux Corporate Information, Head Office, and Major Competitors

Table 15. Phagelux Major Business

Table 16. Phagelux Phage Therapy Product and Solutions

Table 17. Phagelux Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Intralytix Corporate Information, Head Office, and Major Competitors

Table 19. Intralytix Major Business

Table 20. Intralytix Phage Therapy Product and Solutions

Table 21. Intralytix Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Micreos Corporate Information, Head Office, and Major Competitors

Table 23. Micreos Major Business

Table 24. Micreos Phage Therapy Product and Solutions

Table 25. Micreos Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Eliava BioPreparations Corporate Information, Head Office, and Major Competitors

Table 27. Eliava BioPreparations Major Business

Table 28. Eliava BioPreparations Phage Therapy Product and Solutions

Table 29. Eliava BioPreparations Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Locus Biosciences,Inc Corporate Information, Head Office, and Major Competitors

Table 31. Locus Biosciences,Inc Major Business

Table 32. Locus Biosciences,Inc Phage Therapy Product and Solutions

Table 33. Locus Biosciences,Inc Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Pharmex Group,LLC Corporate Information, Head Office, and Major Competitors

Table 35. Pharmex Group,LLC Major Business

Table 36. Pharmex Group,LLC Phage Therapy Product and Solutions

Table 37. Pharmex Group,LLC Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Pherecydes Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Pherecydes Pharma Major Business

Table 40. Pherecydes Pharma Phage Therapy Product and Solutions

Table 41. Pherecydes Pharma Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. APS Biocontrol Ltd. (APS) Corporate Information, Head Office, and Major Competitors

Table 43. APS Biocontrol Ltd. (APS) Major Business

Table 44. APS Biocontrol Ltd. (APS) Phage Therapy Product and Solutions

Table 45. APS Biocontrol Ltd. (APS) Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Qingdao Phagepharm Bio-tech Corporate Information, Head Office, and Major Competitors

Table 47. Qingdao Phagepharm Bio-tech Major Business

Table 48. Qingdao Phagepharm Bio-tech Phage Therapy Product and Solutions

Table 49. Qingdao Phagepharm Bio-tech Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Fixed-Phage Limited Corporate Information, Head Office, and Major Competitors

Table 51. Fixed-Phage Limited Major Business

Table 52. Fixed-Phage Limited Phage Therapy Product and Solutions

Table 53. Fixed-Phage Limited Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Zeptometrix Corporate Information, Head Office, and Major Competitors

Table 55. Zeptometrix Major Business

Table 56. Zeptometrix Phage Therapy Product and Solutions

Table 57. Zeptometrix Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Phage International, Inc. Corporate Information, Head Office, and Major Competitors

Table 59. Phage International, Inc. Major Business

Table 60. Phage International, Inc. Phage Therapy Product and Solutions

Table 61. Phage International, Inc. Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. MicroMir Corporate Information, Head Office, and Major Competitors

Table 63. MicroMir Major Business

Table 64. MicroMir Phage Therapy Product and Solutions

Table 65. MicroMir Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. iNtODEWORLD, Inc. Corporate Information, Head Office, and Major Competitors

Table 67. iNtODEWORLD, Inc. Major Business

Table 68. iNtODEWORLD, Inc. Phage Therapy Product and Solutions

Table 69. iNtODEWORLD, Inc. Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. NEXTBIOTICS Corporate Information, Head Office, and Major Competitors

Table 71. NEXTBIOTICS Major Business

Table 72. NEXTBIOTICS Phage Therapy Product and Solutions

Table 73. NEXTBIOTICS Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Armata Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 75. Armata Pharmaceuticals, Inc. Major Business

Table 76. Armata Pharmaceuticals, Inc. Phage Therapy Product and Solutions

Table 77. Armata Pharmaceuticals, Inc. Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Innophage Corporate Information, Head Office, and Major Competitors

Table 79. Innophage Major Business

Table 80. Innophage Phage Therapy Product and Solutions

Table 81. Innophage Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Adaptive Phage Therapeutics Corporate Information, Head Office, and Major Competitors

Table 83. Adaptive Phage Therapeutics Major Business

Table 84. Adaptive Phage Therapeutics Phage Therapy Product and Solutions

Table 85. Adaptive Phage Therapeutics Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. TechnoPhage Corporate Information, Head Office, and Major Competitors

Table 87. TechnoPhage Major Business

Table 88. TechnoPhage Phage Therapy Product and Solutions

Table 89. TechnoPhage Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Global Phage Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 91. Global Phage Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 92. Breakdown of Phage Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 93. Phage Therapy Players Head Office, Products and Services Provided

Table 94. Phage Therapy Mergers & Acquisitions in the Past Five Years

Table 95. Phage Therapy New Entrants and Expansion Plans

Table 96. Global Phage Therapy Revenue (USD Million) by Type (2017-2022)

Table 97. Global Phage Therapy Revenue Share by Type (2017-2022)

Table 98. Global Phage Therapy Revenue Forecast by Type (2023-2028)

Table 99. Global Phage Therapy Revenue by Application (2017-2022)

Table 100. Global Phage Therapy Revenue Forecast by Application (2023-2028)

Table 101. North America Phage Therapy Revenue by Type (2017-2022) & (USD Million)

Table 102. North America Phage Therapy Revenue by Type (2023-2028) & (USD Million)

Table 103. North America Phage Therapy Revenue by Application (2017-2022) & (USD Million)

Table 104. North America Phage Therapy Revenue by Application (2023-2028) & (USD Million)

Table 105. North America Phage Therapy Revenue by Country (2017-2022) & (USD Million)

Table 106. North America Phage Therapy Revenue by Country (2023-2028) & (USD Million)

Table 107. Europe Phage Therapy Revenue by Type (2017-2022) & (USD Million)

Table 108. Europe Phage Therapy Revenue by Type (2023-2028) & (USD Million)

Table 109. Europe Phage Therapy Revenue by Application (2017-2022) & (USD Million)

Table 110. Europe Phage Therapy Revenue by Application (2023-2028) & (USD Million)

Table 111. Europe Phage Therapy Revenue by Country (2017-2022) & (USD Million)

Table 112. Europe Phage Therapy Revenue by Country (2023-2028) & (USD Million)

Table 113. Asia-Pacific Phage Therapy Revenue by Type (2017-2022) & (USD Million)

Table 114. Asia-Pacific Phage Therapy Revenue by Type (2023-2028) & (USD Million)

Table 115. Asia-Pacific Phage Therapy Revenue by Application (2017-2022) & (USD Million)

Table 116. Asia-Pacific Phage Therapy Revenue by Application (2023-2028) & (USD Million)

Table 117. Asia-Pacific Phage Therapy Revenue by Region (2017-2022) & (USD Million)

Table 118. Asia-Pacific Phage Therapy Revenue by Region (2023-2028) & (USD Million)

Table 119. South America Phage Therapy Revenue by Type (2017-2022) & (USD Million)

Table 120. South America Phage Therapy Revenue by Type (2023-2028) & (USD Million)

Table 121. South America Phage Therapy Revenue by Application (2017-2022) & (USD Million)

Table 122. South America Phage Therapy Revenue by Application (2023-2028) & (USD Million)

Table 123. South America Phage Therapy Revenue by Country (2017-2022) & (USD Million)

Table 124. South America Phage Therapy Revenue by Country (2023-2028) & (USD Million)

Table 125. Middle East & Africa Phage Therapy Revenue by Type (2017-2022) & (USD Million)

Table 126. Middle East & Africa Phage Therapy Revenue by Type (2023-2028) & (USD Million)

Table 127. Middle East & Africa Phage Therapy Revenue by Application (2017-2022) & (USD Million)

Table 128. Middle East & Africa Phage Therapy Revenue by Application (2023-2028) & (USD Million)

Table 129. Middle East & Africa Phage Therapy Revenue by Country (2017-2022) & (USD Million)

Table 130. Middle East & Africa Phage Therapy Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Phage Therapy Picture

Figure 2. Global Phage Therapy Revenue Market Share by Type in 2021

Figure 3. DsDNA Bacteriophage

Figure 4. SsDNA Bacteriophage

Figure 5. SsRNA Bacteriophage

Figure 6. Others

Figure 7. Phage Therapy Revenue Market Share by Application in 2021

Figure 8. Animal Health Picture

Figure 9. Aquaculture Picture

Figure 10. Agriculture Picture

Figure 11. Food Industry Picture

Figure 12. Human Health Picture

Figure 13. Others Picture

Figure 14. Global Phage Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 15. Global Phage Therapy Revenue and Forecast (2017-2028) & (USD Million)

Figure 16. Global Phage Therapy Revenue Market Share by Region (2017-2028)

Figure 17. Global Phage Therapy Revenue Market Share by Region in 2021

Figure 18. North America Phage Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Europe Phage Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Asia-Pacific Phage Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. South America Phage Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Middle East and Africa Phage Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Phage Therapy Market Drivers

Figure 24. Phage Therapy Market Restraints

Figure 25. Phage Therapy Market Trends

Figure 26. NPO Microgen Recent Developments and Future Plans

Figure 27. Proteon Pharmaceuticals Recent Developments and Future Plans

Figure 28. Phagelux Recent Developments and Future Plans

Figure 29. Intralytix Recent Developments and Future Plans

Figure 30. Micreos Recent Developments and Future Plans

Figure 31. Eliava BioPreparations Recent Developments and Future Plans

Figure 32. Locus Biosciences,Inc Recent Developments and Future Plans

Figure 33. Pharmex Group,LLC Recent Developments and Future Plans

Figure 34. Pherecydes Pharma Recent Developments and Future Plans

Figure 35. APS Biocontrol Ltd. (APS) Recent Developments and Future Plans

Figure 36. Qingdao Phagepharm Bio-tech Recent Developments and Future Plans

Figure 37. Fixed-Phage Limited Recent Developments and Future Plans

Figure 38. Zeptometrix Recent Developments and Future Plans

Figure 39. Phage International, Inc. Recent Developments and Future Plans

Figure 40. MicroMir Recent Developments and Future Plans

Figure 41. iNtODEWORLD, Inc. Recent Developments and Future Plans

Figure 42. NEXTBIOTICS Recent Developments and Future Plans

Figure 43. Armata Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 44. Innophage Recent Developments and Future Plans

Figure 45. Adaptive Phage Therapeutics Recent Developments and Future Plans

Figure 46. TechnoPhage Recent Developments and Future Plans

Figure 47. Global Phage Therapy Revenue Share by Players in 2021

Figure 48. Phage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 49. Global Top 3 Players Phage Therapy Revenue Market Share in 2021

Figure 50. Global Top 10 Players Phage Therapy Revenue Market Share in 2021

Figure 51. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 52. Global Phage Therapy Revenue Share by Type in 2021

Figure 53. Global Phage Therapy Market Share Forecast by Type (2023-2028)

Figure 54. Global Phage Therapy Revenue Share by Application in 2021

Figure 55. Global Phage Therapy Market Share Forecast by Application (2023-2028)

Figure 56. North America Phage Therapy Sales Market Share by Type (2017-2028)

Figure 57. North America Phage Therapy Sales Market Share by Application (2017-2028)

Figure 58. North America Phage Therapy Revenue Market Share by Country (2017-2028)

Figure 59. United States Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Canada Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Mexico Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Europe Phage Therapy Sales Market Share by Type (2017-2028)

Figure 63. Europe Phage Therapy Sales Market Share by Application (2017-2028)

Figure 64. Europe Phage Therapy Revenue Market Share by Country (2017-2028)

Figure 65. Germany Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. France Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. United Kingdom Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Russia Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Italy Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Asia-Pacific Phage Therapy Sales Market Share by Type (2017-2028)

Figure 71. Asia-Pacific Phage Therapy Sales Market Share by Application (2017-2028)

Figure 72. Asia-Pacific Phage Therapy Revenue Market Share by Region (2017-2028)

Figure 73. China Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Japan Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. South Korea Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. India Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Southeast Asia Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Australia Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. South America Phage Therapy Sales Market Share by Type (2017-2028)

Figure 80. South America Phage Therapy Sales Market Share by Application (2017-2028)

Figure 81. South America Phage Therapy Revenue Market Share by Country (2017-2028)

Figure 82. Brazil Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Argentina Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Middle East and Africa Phage Therapy Sales Market Share by Type (2017-2028)

Figure 85. Middle East and Africa Phage Therapy Sales Market Share by Application (2017-2028)

Figure 86. Middle East and Africa Phage Therapy Revenue Market Share by Country (2017-2028)

Figure 87. Turkey Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 88. Saudi Arabia Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. UAE Phage Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 90. Methodology

Figure 91. Research Process and Data Source